European Union Trademark No. 001039312 (Word) Trademark register: EUIPO Status: application refused

 
Word mark

TARGETED HIGH-THROUGHPUT DRUG DISCOVERY
The European Union Trademark for TARGETED HIGH-THROUGHPUT DRUG DISCOVERY (Word) was filed on 11.01.1999 for goods and services in class(es) 1, 5 and 42 at the European Union Intellectual Property Office (EUIPO). The current status of the trademark No. 001039312 TARGETED HIGH-THROUGHPUT DRUG DISCOVERY is 'application refused'.


 
Trademark information
NameTARGETED HIGH-THROUGHPUT DRUG DISCOVERY
TypeWord
RegisterEuropean Union Intellectual Property Office (EUIPO)
 
Filing date11.01.1999
 
Nice classes1, 5 and 42
OwnerOy Juvantia Pharma Ltd.
 20520 Turku, FI
 
Representative
 20520 Turku, FI
 
Goods and Services (the trademark is registered for the following goods and services)
Class 1 : Chemical preparations for scientific purposes, especially libraries of chemical compounds; chemical reagents; chemical substances and preparations for use in analyses in laboratories; biological preparations.
Class 5 : Therapeutically active agents, particularly libraries of therapeutically active chemical compounds; pharmaceutical preparations; veterinary preparations; diagnostic preparations for medical or veterinary purposes; biological preparations for medical or veterinary purposes.
Class 42 : Scientific and industrial research, particularly research relating to pharmaceuticals and receptor studies; chemical analysis and research, particularly pharmaceutical screening assays and other bioaffinity assays; pre-synthetic drug design, molecule modelling; chemical synthesis, particularly in the field of combinatorial chemistry.
 
tmdb is a free trademark search website of publicly available records. tmdb does not guarantee nor warrant the accuracy, completeness or timeliness of the data.